Human
Transforming existing hypodermically injected vaccines into an oral solid dose format — addressing SARS-CoV-2, Hepatitis B, HPV, RSV, Meningitis, Malaria, and more.
View human applications →The market opportunities for the PlantPharm BioMed technology include animal as well as human applications. Learn more about each sector opportunity below.
Transforming existing hypodermically injected vaccines into an oral solid dose format — addressing SARS-CoV-2, Hepatitis B, HPV, RSV, Meningitis, Malaria, and more.
View human applications →
Pelletized feed vaccines for farmed animals, wildlife (via bait station), and companion animals — no hypodermic needle required.
View animal health →
An economical oral vaccine option for salmon and shrimp, eliminating individual injection or immersion methods.
View aquaculture →PlantPharm BioMed is seeking investors passionate about biotechnology and a more sustainable global healthcare system.